 |
|
|
|
 |
|
|
Impaired fasting glycaemia
Impaired fasting glycaemia (IFG) is a pre-diabetic state of dysglycemia, associated with insulin resistance and increased risk cardiovascular pathology, although of lesser risk than Impaired glucose tolerance (IGT). IFG often progresses to type 2 diabetes mellitus, a recent study citing the average time for progression as less than three years.[1] IFG is also a risk factor for mortality.[2]
It is characterised by an intermediately raised fasting glucose level, but less than would qualify for type 2 diabetes mellitus. On challenging with an oral glucose tolerance test, normal blood glucose levels are maintained after 2 hours, unlike IGT.
Criteria
The criteria will continue to change as many endocrinologists believe an impaired fasting glycose may eventually include fasting glucose between a high 95-100 mg/dl.
References
- ^ Nichols GA, Hillier TA, Brown JB (2007). "Progression From Newly Acquired Impaired Fasting Glusose to Type 2 Diabetes". Diabetes Care 30: 228-233.
- ^ Barr EL, Zimmet PZ, Welborn TA, et al (2007). "Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)". Circulation 116 (2): 151-7. doi:10.1161/CIRCULATIONAHA.106.685628. PMID 17576864.
- ^ .World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Retrieved on 2007-05-29.
- ^ (2005) "Diagnosis and classification of diabetes mellitus". Diabetes Care 28 Suppl 1: S37-42. PMID 15618111.
See also
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Impaired_fasting_glycaemia". A list of authors is available in Wikipedia.
|
|
|
|
|
|
Top